Subscribe

Ambea AB (publ) (AMBEA.ST)

SEK144.30 +3.20 (+2.27%)
SE STO Healthcare Medical - Care Facilities
Address Evenemangsgatan 21, 6 tr 171 29
Solna, SE
CEO Mark Jensen
Website ambea.se
IPO 2017-03-31
ISIN SE0009663826

Explore sections of this company profile

Also trades on London Stock Exchange · 0RNX.L (SEK) Stockholm Stock Exchange · AMBEA.ST (SEK)
Description

Ambea AB (publ) provides extensive health and social care provisions, encompassing accommodation, support services, educational offerings, and qualified personnel, to senior citizens and individuals with disabilities throughout Sweden, Norway, and Denmark. The company manages its operations through five primary divisions: Nytida, Vardaga, Stendi, Altiden, and Klara. The Nytida segment is dedicated to residential facilities, individual and family assistance, specialized educational institutions for children, adolescents, and adults with disabilities or psychosocial conditions, alongside various day services. Vardaga delivers care specifically for the elderly, featuring nursing homes, short-term residency options, in-home assistance, and day activity programs. Stendi addresses the needs of children, young people, and adults through personal assistance, residential living arrangements, elder care, and home-based support. The Altiden segment's portfolio includes services for the elderly, home care, general social care, and specialized disability support. Finally, Klara offers subscription-based services for mobile care teams and supplies temporary medical staff, such as physicians and nurses. Founded in 1996, Ambea AB (publ) maintains its head office in Solna, Sweden.

Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
SEK144.30 +3.20 (+2.27%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
163.3K
Beta
0.68
Float Shares
71.33M
Free Float %
89.1%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
-0.74% +2.37% +7.23% +25.88% +15.31% +5.84% +36.40% +278.61% +125.31% +97.18% +97.18%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Price Targets & DCF
Current price
144.30
DCF (Unlevered) 1,045.83 +624.8%
DCF (Levered) 888.89 +516.0%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 3 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Quality scores
Altman Z-Score
1.26
Distress
Piotroski F-Score
7 / 9
Strong
MOAT Score
7 / 10
Strong MOAT
Composite Rating
B+
Overall Score
3 / 5
Medium
DCF Score
4 / 5
High
ROE Score
4 / 5
High
ROA Score
4 / 5
High
D/E Score
1 / 5
Low
P/E Score
3 / 5
Medium
P/Book Score
3 / 5
Medium
Operational MOAT
✗ Below peers
  • ✓
    Revenue growth Medical - Care Facilities: +10.2%
    +13.0% ★ Q1'26: +15.8% (vs Q1'25)
  • ✓
    EPS growth Medical - Care Facilities: +19.2%
    +10.0% Q1'26: +45.3% (vs Q1'25)
  • ✓
    FCF margin FCF growth · Medical - Care Facilities: +32.0%
    +11.6% Q1'26: +4.6% (vs Q1'25)
  • ✗
    EBIT margin Medical - Care Facilities: +11.3%
    +7.5% Q1'26: +7.8% (vs Q1'25)
  • ✗
    ROIC Medical - Care Facilities: +6.8%
    +5.3% Q1'26: +5.5% (vs Q1'25)
  • ✓
    Share dilution Medical - Care Facilities: +0.0%
    -2.6% ★ Q1'26: -2.3% (vs Q1'25)
  • ✗
    Debt / EBITDA Net debt/EBITDA · Medical - Care Facilities: 0.99×
    4.67× Q1'26: 4.57× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
▶ WACC components (optional)
Ke (Cost of Equity) = Rf + β (0.60) × ERP
WACC = 49% × Ke + 51% × Kd (4.1%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
—
Intrinsic value (base): 1,045.83 Current price: 144.30
Enterprise Value: — Equity Value: — Terminal Value: — TV as % of EV: —

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2017
actual 		Dec 2018
actual 		Dec 2019
actual 		Dec 2020
actual 		Dec 2021
actual 		Dec 2022
actual 		Dec 2023
actual 		Dec 2024
actual 		Dec 2025
actual 		Dec 2026
3 Rev. Ana.
2 EPS Ana. 		Dec 2027
3 Rev. Ana.
2 EPS Ana. 		Dec 2028
3 Rev. Ana.
2 EPS Ana. 		Dec 2029
2 Rev. Ana.
1 EPS Ana.
Revenue
5.82B
est: 5.84B (-0.4%)
6.08B
est: 6.09B (-0.2%)
11.04B
est: 11.09B (-0.4%)
11.08B
est: 11.03B (+0.5%)
11.48B
est: 11.47B (+0.0%)
12.64B
est: 12.56B (+0.6%)
13.31B
est: 13.77B (-3.3%)
14.20B
est: 14.15B (+0.3%)
16.04B
est: 16.00B (+0.2%)
17.27B
17.09B – 17.56B
+7.9% YoY
17.92B
17.72B – 18.30B
+3.8% YoY
18.68B
18.60B – 18.77B
+4.2% YoY
20.05B
19.84B – 20.44B
+7.3% YoY
EBITDA
571.00M
est: 937.17M (-39.1%)
602.00M
est: 977.29M (-38.4%)
1.38B
est: 1.78B (-22.6%)
1.61B
est: 1.77B (-8.8%)
1.62B
est: 1.84B (-12.3%)
2.04B
est: 2.02B (+1.1%)
2.28B
est: 2.27B (+0.3%)
2.61B
est: 2.34B (+11.6%)
2.71B
est: 2.64B (+2.4%)
2.85B
2.82B – 2.90B
+7.9% YoY
2.96B
2.93B – 3.02B
+3.8% YoY
3.09B
3.07B – 3.10B
+4.2% YoY
3.31B
3.28B – 3.38B
+7.3% YoY
EBIT
341.00M
est: 398.67M (-14.5%)
409.00M
est: 415.73M (-1.6%)
537.00M
est: 757.26M (-29.1%)
718.00M
est: 753.19M (-4.7%)
563.00M
est: 783.61M (-28.2%)
838.00M
est: 857.95M (-2.3%)
984.00M
est: 968.40M (+1.6%)
1.24B
est: 995.17M (+24.7%)
1.20B
est: 1.13B (+6.8%)
1.21B
1.20B – 1.24B
+7.9% YoY
1.26B
1.25B – 1.29B
+3.8% YoY
1.31B
1.31B – 1.32B
+4.2% YoY
1.41B
1.40B – 1.44B
+7.3% YoY
Net Income
226.00M
est: 322.31M (-29.9%)
295.00M
est: 440.75M (-33.1%)
215.00M
est: 418.31M (-48.6%)
359.00M
est: 402.75M (-10.9%)
237.00M
est: 425.12M (-44.3%)
366.00M
est: 380.52M (-3.8%)
455.00M
est: 518.80M (-12.3%)
620.00M
est: 676.16M (-8.3%)
665.00M
est: 776.37M (-14.3%)
934.81M
874.25M – 995.37M
+20.4% YoY
1.03B
963.06M – 1.11B
+10.7% YoY
1.10B
1.08B – 1.12B
+6.1% YoY
1.11B
1.09B – 1.14B
+0.9% YoY
SGA
291.00M
est: 391.53M (-25.7%)
281.00M
est: 408.29M (-31.2%)
528.00M
est: 743.70M (-29.0%)
450.00M
est: 739.69M (-39.2%)
466.00M
est: 769.57M (-39.4%)
1.47B
est: 842.58M (+74.9%)
1.43B
est: 811.77M (+76.7%)
423.00M
est: 834.21M (-49.3%)
—
est: 943.57M (-100.0%)
1.02B
1.01B – 1.04B
+7.9% YoY
1.06B
1.04B – 1.08B
+3.8% YoY
1.10B
1.10B – 1.11B
+4.2% YoY
1.18B
1.17B – 1.20B
+7.3% YoY
EPS
3.04
est: 3.74 (-18.8%)
3.94
est: 5.12 (-23.0%)
2.51
est: 4.86 (-48.3%)
3.80
est: 4.68 (-18.7%)
2.51
est: 4.94 (-49.1%)
3.89
est: 4.42 (-11.9%)
5.07
est: 6.15 (-17.5%)
7.21
est: 8.01 (-10.0%)
7.95
est: 9.20 (-13.6%)
10.91
10.42 – 11.86
+18.6% YoY
12.26
11.47 – 13.18
+12.4% YoY
13.08
12.87 – 13.29
+6.7% YoY
13.20
13.01 – 13.53
+0.9% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-08 B+ 3/5 4/5 4/5 4/5 1/5 3/5 3/5
2026-05-07 B+ 3/5 4/5 4/5 4/5 1/5 3/5 3/5
2026-05-06 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-05-05 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-05-04 B+ 3/5 4/5 4/5 4/5 1/5 3/5 3/5
2026-04-30 B+ 3/5 4/5 4/5 4/5 1/5 3/5 3/5
2026-04-29 B+ 3/5 4/5 4/5 4/5 1/5 3/5 3/5
2026-04-28 B+ 3/5 4/5 4/5 4/5 1/5 3/5 3/5
2026-04-27 B+ 3/5 4/5 4/5 4/5 1/5 3/5 3/5
2026-04-24 A- 4/5 5/5 4/5 4/5 1/5 3/5 3/5
2026-04-23 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-22 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-21 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-20 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-17 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5
2026-04-16 A- 4/5 5/5 4/5 5/5 1/5 3/5 3/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
3.30B
OE per share TTM
39.51
Owner's Yield
27.65%
Maintenance CapEx ratio
181.92%
Maint CapEx / Avg PPE
59.2%

Ownership Overview

Ownership breakdown

Ownership breakdown not available.

At a glance
Institutional holders
—
Total invested
—
Insider transactions (90d)
0
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend

Institutional history not available.

Top institutional holders

Top holders not available.

ETF Ownership

Top ETFs holding this stock Held by 64 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 Xtrackers Bloomberg Commodity Swap UCITS ETF 1C XCMC.L 0.59% 5.31M 0.12%
2 WisdomTree Europe SmallCap Dividend UCITS ETF WTES.DE 0.19% 170.1K 0.38%
3 WisdomTree Europe SmallCap Dividend UCITS ETF Acc DFEA.L 0.19% 170.1K 0.38%
4 JPMorgan International Value ETF JIVE 0.19% 5.98M 0.55%
5 iShares Ageing Population UCITS ETF AGED.L 0.11% 940.4K 0.40%
6 Xtrackers S&P 500 Swap UCITS ETF 5C EUR Hedged XS5E.DE 0.08% 8.72M 0.20%
7 Xtrackers S&P 500 Swap UCITS ETF 1D XSXD.L 0.08% 8.73M 0.07%
8 Xtrackers S&P 500 Swap UCITS ETF XS5G.L 0.08% 8.73M 0.20%
9 Xtrackers S&P 500 Swap UCITS ETF 1C XSPU.L 0.08% 8.73M 0.15%
10 WisdomTree International SmallCap Dividend Fund DLS 0.08% 873.2K 0.58%

Insider Activity

Insider Activity — Latest Quarter

No insider activity available.

Insider buys vs sells (history)

Insider history not available.

Recent insider transactions

No recent insider transactions.

Executive team

Top executives
EBIT / Employee
31.6K
Shares Outstanding
80.10M

Executive compensation

Executive compensation (annual)

Executive compensation not available.

CEO compensation breakdown

No CEO compensation history available.

Proxy statements

Proxy statements (DEF 14A)

No proxy statements available for this company yet.

Recent SEC filings

Recent SEC filings

No SEC filings available for this company yet.

Executive team

NameTitleCompensationGender
Mark Jensen Chief Executive Officer & President 12M male
Benno Eliasson Chief Financial Officer 1M male
Elin Delvert Head of HR and Sustainability — female
Erika Enestad Head of Quality & Sustainability — female
Fredrik von Malmborg Managing Director of Nytida — male
Ingvild Kristiansen Managing Director of Stendi — female
Max Törnqvist Head of Public Affairs & Press — male
Susanne Sjoberg Managing Director of Vardaga — female
Susanne Vogt Head of IR, Reporting & Group Business Control — female
Christian Horne Head of Talent Management & Development — male
ESG Score History

No data available for this company.

Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend yield history

Dividend history

Earnings history

Earnings reports

Stock splits

Related companies

Largest companies in Medical - Care Facilities